Banque Cantonale Vaudoise Glaukos Corp Transaction History

Banque Cantonale Vaudoise

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$59.53 - $85.11 $121,203 - $173,283	-2,036 Reduced 37.0%	3,467 $276,000
Q2 2023 Aug 09, 2023	BUY	$45.44 - $71.21 $250,056 - $391,868	5,503 New	5,503 $392,000
Q2 2022 Aug 02, 2022	SELL	$34.86 - $63.77 $293,033 - $536,050	-8,406 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$44.33 - $57.82 $372,637 - $486,034	8,406 New	8,406 $486,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.